Mindfulness can be described as a psychological concept which is well established within the scientific literature and commonly discussed in association with meditation. It is often broken down into two separate subcomponents which comprise this effect.
The first of these components involves the self-regulation of attention so that its focus is completely directed towards immediate experience, thereby quietening one's internal narrative and allowing for increased recognition of external and mental events within the present moment.
The second of these components involves adopting a particular orientation toward one’s experiences in the present moment that is characterized by a lack of judgement, curiosity, openness, and acceptance.
Within meditation, this state of mind is deliberately practiced and maintained via the conscious and manual redirection of one's awareness towards a singular point of focus for extended periods of time. However, within the context of psychoactive substance usage, this state is often spontaneously induced without any conscious effort or the need of any prior knowledge regarding meditative techniques.
Although mindfulness usually occurs spontaneously with no immediate trigger, it is considerably more common when the person is also undergoing both anxiety suppression and focus enhancement. It primarily occurs under the influence of heavy dosages of hallucinogenic compounds such as psychedelics, dissociatives, cannabinoids. However, it can also occur on entactogens, certain nootropics such as l-theanine, and during simultaneous doses of benzodiazepines and stimulants.
Compounds which may cause this effect commonly include:
2C-C, 4-AcO-DMT, 4-AcO-DiPT, 4-HO-DPT, 5-Hydroxytryptophan, 5-MeO-DMT, 5F-AKB48, 5F-PB-22, 6-APB, 6-APDB, APICA, Alpha-GPC, Aniracetam, Ayahuasca, Bromo-DragonFLY, Bufotenin, Butylone, Cannabis, Citicoline, Coluracetam, DMT, Escaline, Ethylone, Ibogaine, LSA, LSZ, MDA, MDAI, MDEA, MDMA, MET, N-Acetylcysteine, Oxiracetam, Phenylpiracetam, Piracetam, Pramiracetam, Psilocin, Psilocybin mushroom, STS-135, THJ-018, THJ-2201, Theanine
Documentation written by Josie Kins